Hypoactive APOBEC3A Achieves High-Level Mutagenesis and Drives Squamous Cell Carcinoma.

APOBEC proteins shape the somatic mutation spectrum of many cancers by binding and editing DNA. Modeling APOBEC-induced changes in cancer has been challenging due to the toxicity of these enzymes. Here, we overcame this barrier using a mutant form of APOBEC3A with impaired deaminase activity by changing arginine 128 to alanine (A3AR128A). Overexpressing A3AR128A in murine epithelium induced squamous cell carcinoma (SCC) in the skin, head and neck region, and cervix, mirroring the human disease spectrum. Tumor formation was further accelerated by concomitant Trp53 loss. A3AR128A cancers carried frequent alterations in the NOTCH and RAS-PI3K pathways, and recurrent mutations in genes encoding histone H3 were also observed. Cross-species analysis revealed how APOBEC accessibility influences cancer driver gene selection. A catalogue of 235,790 mutations was used to refine mutational signatures linked to A3A. These results shed light on how DNA damage from A3A contributes to tumorigenesis.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-11-16
DOI
https://doi.org/10.1158/0008-5472.can-25-5211
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hypoactive APOBEC3A Achieves High-Level Mutagenesis and Drives Squamous Cell Carcinoma.

Ian J. Majewski, Lorraine Ann O’Reilly, Christoffer Flensburg, Lachlan W. Whitehead et al.
1 links
Cancer Research
Cancer Genomics and Diagnostics
article

Hypoactive APOBEC3A Achieves High-Level Mutagenesis and Drives Squamous Cell Carcinoma.

Ian J. Majewski, Lorraine Ann O’Reilly, Christoffer Flensburg, Lachlan W. Whitehead, Rebecca A. Bilardi, Andrew J. Kueh, Danielle K. Boyd, Zhen Xu, Kate D. Sutherland
article en

Abstract

APOBEC proteins shape the somatic mutation spectrum of many cancers by binding and editing DNA. Modeling APOBEC-induced changes in cancer has been challenging due to the toxicity of these enzymes. Here, we overcame this barrier using a mutant form of APOBEC3A with impaired deaminase activity by changing arginine 128 to alanine (A3AR128A). Overexpressing A3AR128A in murine epithelium induced squamous cell carcinoma (SCC) in the skin, head and neck region, and cervix, mirroring the human disease spectrum. Tumor formation was further accelerated by concomitant Trp53 loss. A3AR128A cancers carried frequent alterations in the NOTCH and RAS-PI3K pathways, and recurrent mutations in genes encoding histone H3 were also observed. Cross-species analysis revealed how APOBEC accessibility influences cancer driver gene selection. A catalogue of 235,790 mutations was used to refine mutational signatures linked to A3A. These results shed light on how DNA damage from A3A contributes to tumorigenesis.

Cancer Research
Walter and Eliza Hall Institute of Medical Research (AU), Olivia Newton-John Cancer Wellness & Research Centre (AU)
Good health and well-being
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon